Cargando…
Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer
Exploring ERBB2-related pathways will help us finding sensitive molecules and potential combined therapeutic targets of ERBB2-targeted therapy for ERBB2+ gastric cancer (GC). In this study, we performed a cross-databases study focused on ERBB2+ GC. The data of ERBB2+ GC deposited in the cancer genom...
Autores principales: | Xiang, Zhen, Huang, Xia, Wang, Jiexuan, Zhang, Jun, Ji, Jun, Yan, Ranlin, Zhu, Zhenggang, Cai, Wei, Yu, Yingyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085474/ https://www.ncbi.nlm.nih.gov/pubmed/30123134 http://dx.doi.org/10.3389/fphar.2018.00861 |
Ejemplares similares
-
Genetic Profiles Affect the Biological Effects of Serine on Gastric Cancer Cells
por: Li, Jun, et al.
Publicado: (2020) -
A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis
por: Xiang, Zhen, et al.
Publicado: (2019) -
Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways
por: Xiang, Zhen, et al.
Publicado: (2021) -
UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability
por: Zhang, Jun, et al.
Publicado: (2018) -
A Novel Citrullinated Modification of Histone 3 and Its Regulatory Mechanisms Related to IPO-38 Antibody-Labeled Protein
por: Song, Shuzheng, et al.
Publicado: (2019)